Threshold Pharmaceuticals

Threshold Pharmaceuticals

Verified
Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$164—246m (Dealroom.co estimates Jan 2004.)
San Francisco California (HQ)
  • Edit

Recent News about Threshold Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.